title: Spasm provocation tests performed under medical therapy: a new approach for treating patients with refractory coronary spastic angina on emergency admission.
abstract: Objective There are no objective methods for evaluating the severity of vasospasms in patients with refractory coronary spastic angina (R-CSA) under adequate medical therapy. We examined whether spasm provocation tests performed under adequate medication are useful for evaluating the severity of disease in R-CSA patients on emergency admission. Methods and Results We performed spasm provocation tests before and after the administration of medical therapy in eight R-CSA patients, including one ventricular fibrillation survivor (VF-S) and seven patients with unstable angina (UAP) on emergency readmission. We also performed these tests only after medical therapy on urgent admission in four R-CSA patients, including two patients with UAP, one patient with VF-S and one patient with acute coronary syndrome. All 12 R-CSA patients had been medicated with ≥ 2 vasodilator drugs. Positive coronary spasms were defined as >99% transient narrowing. The coronary artery spasms disappeared in three patients under medication, and mitigation of vasospasticity was observed in three patients. In these six cases we continued the same medications. Meanwhile in two patients, we recommended a consultation for psychosomatic medicine. In contrast, the remaining six R-CSA patients exhibited higher levels of vasospasticity, irrespective of the administration of aggressive medical therapy, in which the doses of vasoactive drugs were increased in order to suppress coronary artery spasms. Conclusion In some R-CSA patients on emergency admission, performing spasm provocation tests under medical therapy is useful for determining the subsequent treatment strategy. Therefore, this test may become a new tool in the treatment of R-CSA.
authors.affiliation: Department of Cardiology, Ehime Niihama Prefectural Hospital, Japan.
authors.forename: Shozo
authors.initials: S
authors.lastname: Sueda
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Kohno
authors.forename: Toru
authors.initials: T
authors.lastname: Miyoshi
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Sasaki
authors.forename: Tomoki
authors.initials: T
authors.lastname: Sakaue
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Habara
mesh_terms: D000109:Acetylcholine; D000368:Aged; D000787:Angina Pectoris / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D001783:Blood Flow Velocity / Q000187:drug effects; D017023:Coronary Angiography / Q000379:methods; D003329:Coronary Vasospasm / Q000139:chemically induced / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D008297:Male; D009128:Muscle Spasticity; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage*
chemical_list: D014665:Vasodilator Agents; D000109:Acetylcholine